nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—lung cancer	0.29	1	CbGaD
Vecuronium—ABCB1—Topotecan—lung cancer	0.0465	0.136	CbGbCtD
Vecuronium—ABCB1—Gefitinib—lung cancer	0.0425	0.124	CbGbCtD
Vecuronium—ABCB1—Vinorelbine—lung cancer	0.0327	0.0957	CbGbCtD
Vecuronium—ABCB1—Crizotinib—lung cancer	0.0261	0.0762	CbGbCtD
Vecuronium—ABCB1—Gemcitabine—lung cancer	0.0255	0.0745	CbGbCtD
Vecuronium—ABCB1—Erlotinib—lung cancer	0.0251	0.0735	CbGbCtD
Vecuronium—CHRND—pericardium—lung cancer	0.0234	0.612	CbGeAlD
Vecuronium—ABCB1—Paclitaxel—lung cancer	0.023	0.0673	CbGbCtD
Vecuronium—ABCB1—Irinotecan—lung cancer	0.0227	0.0664	CbGbCtD
Vecuronium—ABCB1—Vinblastine—lung cancer	0.0202	0.059	CbGbCtD
Vecuronium—ABCB1—Cisplatin—lung cancer	0.0185	0.0541	CbGbCtD
Vecuronium—ABCB1—Etoposide—lung cancer	0.0182	0.0532	CbGbCtD
Vecuronium—ABCB1—Docetaxel—lung cancer	0.0166	0.0486	CbGbCtD
Vecuronium—ABCB1—Doxorubicin—lung cancer	0.0124	0.0363	CbGbCtD
Vecuronium—ABCB1—Methotrexate—lung cancer	0.012	0.0351	CbGbCtD
Vecuronium—Respiratory insufficiency—Pemetrexed—lung cancer	0.00802	0.0571	CcSEcCtD
Vecuronium—CHRNA2—mammary gland—lung cancer	0.00464	0.121	CbGeAlD
Vecuronium—CHRND—respiratory system—lung cancer	0.00446	0.117	CbGeAlD
Vecuronium—Respiratory failure—Crizotinib—lung cancer	0.0027	0.0192	CcSEcCtD
Vecuronium—Respiratory failure—Pemetrexed—lung cancer	0.00246	0.0176	CcSEcCtD
Vecuronium—Respiratory failure—Gefitinib—lung cancer	0.00245	0.0174	CcSEcCtD
Vecuronium—CHRND—lung—lung cancer	0.00237	0.0619	CbGeAlD
Vecuronium—Myopathy—Erlotinib—lung cancer	0.00205	0.0146	CcSEcCtD
Vecuronium—Rash erythematous—Topotecan—lung cancer	0.0019	0.0135	CcSEcCtD
Vecuronium—Face oedema—Crizotinib—lung cancer	0.00186	0.0132	CcSEcCtD
Vecuronium—Muscular weakness—Crizotinib—lung cancer	0.0017	0.0121	CcSEcCtD
Vecuronium—Injection site pain—Vinorelbine—lung cancer	0.00152	0.0108	CcSEcCtD
Vecuronium—Respiratory failure—Topotecan—lung cancer	0.00148	0.0105	CcSEcCtD
Vecuronium—Respiratory failure—Vinorelbine—lung cancer	0.00127	0.00902	CcSEcCtD
Vecuronium—Redness—Paclitaxel—lung cancer	0.00124	0.00882	CcSEcCtD
Vecuronium—Injection site reaction—Vinorelbine—lung cancer	0.00124	0.0088	CcSEcCtD
Vecuronium—Cardiac disorder—Crizotinib—lung cancer	0.00123	0.00879	CcSEcCtD
Vecuronium—Bronchospasm—Teniposide—lung cancer	0.00121	0.00862	CcSEcCtD
Vecuronium—Mediastinal disorder—Crizotinib—lung cancer	0.0012	0.00854	CcSEcCtD
Vecuronium—Cardiac disorder—Gefitinib—lung cancer	0.00112	0.00798	CcSEcCtD
Vecuronium—Angiopathy—Gefitinib—lung cancer	0.0011	0.00781	CcSEcCtD
Vecuronium—Rash erythematous—Paclitaxel—lung cancer	0.00109	0.00778	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Topotecan—lung cancer	0.00109	0.00776	CcSEcCtD
Vecuronium—Mediastinal disorder—Gefitinib—lung cancer	0.00109	0.00775	CcSEcCtD
Vecuronium—Erythema—Pemetrexed—lung cancer	0.00106	0.00754	CcSEcCtD
Vecuronium—Redness—Docetaxel—lung cancer	0.00105	0.00748	CcSEcCtD
Vecuronium—CHRNB1—lymph node—lung cancer	0.00104	0.0273	CbGeAlD
Vecuronium—Respiratory failure—Gemcitabine—lung cancer	0.00102	0.00724	CcSEcCtD
Vecuronium—Apnoea—Etoposide—lung cancer	0.00101	0.00717	CcSEcCtD
Vecuronium—Injection site reaction—Gemcitabine—lung cancer	0.000993	0.00707	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Crizotinib—lung cancer	0.000979	0.00697	CcSEcCtD
Vecuronium—Angioedema—Gefitinib—lung cancer	0.000961	0.00684	CcSEcCtD
Vecuronium—Shock—Crizotinib—lung cancer	0.00093	0.00662	CcSEcCtD
Vecuronium—Nervous system disorder—Crizotinib—lung cancer	0.000927	0.0066	CcSEcCtD
Vecuronium—Rash erythematous—Docetaxel—lung cancer	0.000925	0.00659	CcSEcCtD
Vecuronium—Skin disorder—Crizotinib—lung cancer	0.000918	0.00654	CcSEcCtD
Vecuronium—Flushing—Teniposide—lung cancer	0.000914	0.00651	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Pemetrexed—lung cancer	0.000895	0.00637	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Gefitinib—lung cancer	0.000889	0.00633	CcSEcCtD
Vecuronium—Anaphylactic shock—Pemetrexed—lung cancer	0.000864	0.00615	CcSEcCtD
Vecuronium—Respiratory failure—Paclitaxel—lung cancer	0.000851	0.00607	CcSEcCtD
Vecuronium—Shock—Pemetrexed—lung cancer	0.00085	0.00605	CcSEcCtD
Vecuronium—Nervous system disorder—Pemetrexed—lung cancer	0.000847	0.00603	CcSEcCtD
Vecuronium—Shock—Gefitinib—lung cancer	0.000844	0.00601	CcSEcCtD
Vecuronium—Nervous system disorder—Gefitinib—lung cancer	0.000841	0.00599	CcSEcCtD
Vecuronium—Skin disorder—Pemetrexed—lung cancer	0.000839	0.00598	CcSEcCtD
Vecuronium—Skin disorder—Gefitinib—lung cancer	0.000833	0.00594	CcSEcCtD
Vecuronium—Injection site reaction—Paclitaxel—lung cancer	0.000831	0.00592	CcSEcCtD
Vecuronium—Hypotension—Gefitinib—lung cancer	0.000802	0.00571	CcSEcCtD
Vecuronium—Muscular weakness—Vinorelbine—lung cancer	0.000796	0.00567	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Irinotecan—lung cancer	0.000769	0.00548	CcSEcCtD
Vecuronium—Bronchospasm—Vinorelbine—lung cancer	0.000767	0.00546	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Gemcitabine—lung cancer	0.000749	0.00534	CcSEcCtD
Vecuronium—Paralysis—Methotrexate—lung cancer	0.000735	0.00524	CcSEcCtD
Vecuronium—Respiratory failure—Docetaxel—lung cancer	0.000722	0.00514	CcSEcCtD
Vecuronium—Connective tissue disorder—Erlotinib—lung cancer	0.00071	0.00505	CcSEcCtD
Vecuronium—Injection site reaction—Docetaxel—lung cancer	0.000705	0.00502	CcSEcCtD
Vecuronium—Face oedema—Gemcitabine—lung cancer	0.0007	0.00499	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Cisplatin—lung cancer	0.000698	0.00497	CcSEcCtD
Vecuronium—Urticaria—Pemetrexed—lung cancer	0.000686	0.00489	CcSEcCtD
Vecuronium—Tachycardia—Teniposide—lung cancer	0.000683	0.00486	CcSEcCtD
Vecuronium—Urticaria—Gefitinib—lung cancer	0.000682	0.00486	CcSEcCtD
Vecuronium—Angiopathy—Topotecan—lung cancer	0.000662	0.00472	CcSEcCtD
Vecuronium—Immune system disorder—Topotecan—lung cancer	0.000659	0.0047	CcSEcCtD
Vecuronium—Mediastinal disorder—Topotecan—lung cancer	0.000658	0.00469	CcSEcCtD
Vecuronium—Redness—Doxorubicin—lung cancer	0.000655	0.00467	CcSEcCtD
Vecuronium—Hypotension—Teniposide—lung cancer	0.000654	0.00466	CcSEcCtD
Vecuronium—Face oedema—Cisplatin—lung cancer	0.000652	0.00465	CcSEcCtD
Vecuronium—Mediastinal disorder—Erlotinib—lung cancer	0.000651	0.00464	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Etoposide—lung cancer	0.00064	0.00456	CcSEcCtD
Vecuronium—Paralysis—Doxorubicin—lung cancer	0.000637	0.00454	CcSEcCtD
Vecuronium—Hypersensitivity—Pemetrexed—lung cancer	0.000636	0.00453	CcSEcCtD
Vecuronium—Hypersensitivity—Gefitinib—lung cancer	0.000632	0.0045	CcSEcCtD
Vecuronium—Erythema—Erlotinib—lung cancer	0.000629	0.00448	CcSEcCtD
Vecuronium—Bronchospasm—Gemcitabine—lung cancer	0.000616	0.00439	CcSEcCtD
Vecuronium—Connective tissue disorder—Vinorelbine—lung cancer	0.000613	0.00437	CcSEcCtD
Vecuronium—Apnoea—Methotrexate—lung cancer	0.000603	0.00429	CcSEcCtD
Vecuronium—Rash—Crizotinib—lung cancer	0.000596	0.00424	CcSEcCtD
Vecuronium—Dermatitis—Crizotinib—lung cancer	0.000595	0.00424	CcSEcCtD
Vecuronium—ABCB1—respiratory system—lung cancer	0.000584	0.0152	CbGeAlD
Vecuronium—Angioedema—Topotecan—lung cancer	0.00058	0.00414	CcSEcCtD
Vecuronium—Flushing—Vinorelbine—lung cancer	0.000579	0.00413	CcSEcCtD
Vecuronium—Cardiac disorder—Vinorelbine—lung cancer	0.000579	0.00413	CcSEcCtD
Vecuronium—Rash erythematous—Doxorubicin—lung cancer	0.000578	0.00411	CcSEcCtD
Vecuronium—Angiopathy—Vinorelbine—lung cancer	0.000566	0.00403	CcSEcCtD
Vecuronium—Immune system disorder—Vinorelbine—lung cancer	0.000564	0.00402	CcSEcCtD
Vecuronium—Mediastinal disorder—Vinorelbine—lung cancer	0.000563	0.00401	CcSEcCtD
Vecuronium—Urticaria—Teniposide—lung cancer	0.000556	0.00396	CcSEcCtD
Vecuronium—Rash—Pemetrexed—lung cancer	0.000545	0.00388	CcSEcCtD
Vecuronium—Dermatitis—Pemetrexed—lung cancer	0.000544	0.00388	CcSEcCtD
Vecuronium—Erythema—Vinorelbine—lung cancer	0.000543	0.00387	CcSEcCtD
Vecuronium—Injection site pain—Doxorubicin—lung cancer	0.000542	0.00386	CcSEcCtD
Vecuronium—Rash—Gefitinib—lung cancer	0.000541	0.00385	CcSEcCtD
Vecuronium—Dermatitis—Gefitinib—lung cancer	0.000541	0.00385	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.000537	0.00383	CcSEcCtD
Vecuronium—Muscular weakness—Paclitaxel—lung cancer	0.000535	0.00381	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.000531	0.00379	CcSEcCtD
Vecuronium—Bronchospasm—Etoposide—lung cancer	0.000526	0.00375	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—lung cancer	0.00052	0.00371	CcSEcCtD
Vecuronium—Anaphylactic shock—Topotecan—lung cancer	0.000518	0.00369	CcSEcCtD
Vecuronium—Hypersensitivity—Teniposide—lung cancer	0.000515	0.00367	CcSEcCtD
Vecuronium—Nervous system disorder—Topotecan—lung cancer	0.000508	0.00362	CcSEcCtD
Vecuronium—Connective tissue disorder—Irinotecan—lung cancer	0.000506	0.0036	CcSEcCtD
Vecuronium—Shock—Erlotinib—lung cancer	0.000505	0.0036	CcSEcCtD
Vecuronium—Skin disorder—Topotecan—lung cancer	0.000504	0.00359	CcSEcCtD
Vecuronium—Nervous system disorder—Erlotinib—lung cancer	0.000503	0.00358	CcSEcCtD
Vecuronium—Skin disorder—Erlotinib—lung cancer	0.000498	0.00355	CcSEcCtD
Vecuronium—Angioedema—Vinorelbine—lung cancer	0.000497	0.00354	CcSEcCtD
Vecuronium—Connective tissue disorder—Gemcitabine—lung cancer	0.000493	0.00351	CcSEcCtD
Vecuronium—ABCB1—epithelium—lung cancer	0.000488	0.0127	CbGeAlD
Vecuronium—Flushing—Irinotecan—lung cancer	0.000478	0.0034	CcSEcCtD
Vecuronium—Cardiac disorder—Irinotecan—lung cancer	0.000478	0.0034	CcSEcCtD
Vecuronium—Angiopathy—Irinotecan—lung cancer	0.000467	0.00333	CcSEcCtD
Vecuronium—Cardiac disorder—Gemcitabine—lung cancer	0.000465	0.00332	CcSEcCtD
Vecuronium—Immune system disorder—Irinotecan—lung cancer	0.000465	0.00331	CcSEcCtD
Vecuronium—Mediastinal disorder—Irinotecan—lung cancer	0.000464	0.00331	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000459	0.00327	CcSEcCtD
Vecuronium—Connective tissue disorder—Cisplatin—lung cancer	0.000459	0.00327	CcSEcCtD
Vecuronium—Angiopathy—Gemcitabine—lung cancer	0.000455	0.00324	CcSEcCtD
Vecuronium—Immune system disorder—Gemcitabine—lung cancer	0.000453	0.00323	CcSEcCtD
Vecuronium—Mediastinal disorder—Gemcitabine—lung cancer	0.000452	0.00322	CcSEcCtD
Vecuronium—Anaphylactic shock—Vinorelbine—lung cancer	0.000444	0.00316	CcSEcCtD
Vecuronium—Rash—Teniposide—lung cancer	0.000441	0.00314	CcSEcCtD
Vecuronium—Dermatitis—Teniposide—lung cancer	0.000441	0.00314	CcSEcCtD
Vecuronium—Injection site reaction—Doxorubicin—lung cancer	0.00044	0.00313	CcSEcCtD
Vecuronium—Bronchospasm—Docetaxel—lung cancer	0.000437	0.00312	CcSEcCtD
Vecuronium—Erythema—Gemcitabine—lung cancer	0.000437	0.00311	CcSEcCtD
Vecuronium—Nervous system disorder—Vinorelbine—lung cancer	0.000435	0.0031	CcSEcCtD
Vecuronium—Cardiac disorder—Cisplatin—lung cancer	0.000434	0.00309	CcSEcCtD
Vecuronium—Flushing—Cisplatin—lung cancer	0.000434	0.00309	CcSEcCtD
Vecuronium—Tachycardia—Vinorelbine—lung cancer	0.000433	0.00308	CcSEcCtD
Vecuronium—ABCB1—trachea—lung cancer	0.000432	0.0113	CbGeAlD
Vecuronium—Skin disorder—Vinorelbine—lung cancer	0.000431	0.00307	CcSEcCtD
Vecuronium—Immune system disorder—Cisplatin—lung cancer	0.000422	0.00301	CcSEcCtD
Vecuronium—Mediastinal disorder—Cisplatin—lung cancer	0.000421	0.003	CcSEcCtD
Vecuronium—Hypotension—Vinorelbine—lung cancer	0.000414	0.00295	CcSEcCtD
Vecuronium—Connective tissue disorder—Paclitaxel—lung cancer	0.000413	0.00294	CcSEcCtD
Vecuronium—Urticaria—Topotecan—lung cancer	0.000412	0.00293	CcSEcCtD
Vecuronium—Erythema—Cisplatin—lung cancer	0.000407	0.0029	CcSEcCtD
Vecuronium—Flushing—Etoposide—lung cancer	0.000397	0.00283	CcSEcCtD
Vecuronium—Cardiac disorder—Etoposide—lung cancer	0.000397	0.00283	CcSEcCtD
Vecuronium—Hypersensitivity—Vinblastine—lung cancer	0.000393	0.0028	CcSEcCtD
Vecuronium—Cardiac disorder—Paclitaxel—lung cancer	0.00039	0.00278	CcSEcCtD
Vecuronium—Flushing—Paclitaxel—lung cancer	0.00039	0.00278	CcSEcCtD
Vecuronium—Angiopathy—Etoposide—lung cancer	0.000389	0.00277	CcSEcCtD
Vecuronium—Immune system disorder—Etoposide—lung cancer	0.000387	0.00276	CcSEcCtD
Vecuronium—Mediastinal disorder—Etoposide—lung cancer	0.000386	0.00275	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—lung cancer	0.000383	0.00273	CcSEcCtD
Vecuronium—Hypersensitivity—Topotecan—lung cancer	0.000382	0.00272	CcSEcCtD
Vecuronium—Angiopathy—Paclitaxel—lung cancer	0.000381	0.00271	CcSEcCtD
Vecuronium—Immune system disorder—Paclitaxel—lung cancer	0.000379	0.0027	CcSEcCtD
Vecuronium—Mediastinal disorder—Paclitaxel—lung cancer	0.000378	0.0027	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000369	0.00263	CcSEcCtD
Vecuronium—Anaphylactic shock—Irinotecan—lung cancer	0.000366	0.00261	CcSEcCtD
Vecuronium—Erythema—Paclitaxel—lung cancer	0.000366	0.0026	CcSEcCtD
Vecuronium—Shock—Irinotecan—lung cancer	0.00036	0.00256	CcSEcCtD
Vecuronium—Nervous system disorder—Irinotecan—lung cancer	0.000359	0.00256	CcSEcCtD
Vecuronium—Anaphylactic shock—Gemcitabine—lung cancer	0.000356	0.00254	CcSEcCtD
Vecuronium—Urticaria—Vinorelbine—lung cancer	0.000352	0.00251	CcSEcCtD
Vecuronium—Connective tissue disorder—Docetaxel—lung cancer	0.00035	0.00249	CcSEcCtD
Vecuronium—Nervous system disorder—Gemcitabine—lung cancer	0.000349	0.00249	CcSEcCtD
Vecuronium—Skin disorder—Gemcitabine—lung cancer	0.000346	0.00247	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000344	0.00245	CcSEcCtD
Vecuronium—ABCB1—bone marrow—lung cancer	0.000342	0.00894	CbGeAlD
Vecuronium—Hypotension—Irinotecan—lung cancer	0.000342	0.00243	CcSEcCtD
Vecuronium—Angioedema—Paclitaxel—lung cancer	0.000334	0.00238	CcSEcCtD
Vecuronium—Hypotension—Gemcitabine—lung cancer	0.000333	0.00237	CcSEcCtD
Vecuronium—Anaphylactic shock—Cisplatin—lung cancer	0.000332	0.00237	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000332	0.00236	CcSEcCtD
Vecuronium—Cardiac disorder—Docetaxel—lung cancer	0.00033	0.00235	CcSEcCtD
Vecuronium—Flushing—Docetaxel—lung cancer	0.00033	0.00235	CcSEcCtD
Vecuronium—Rash—Topotecan—lung cancer	0.000327	0.00233	CcSEcCtD
Vecuronium—Hypersensitivity—Vinorelbine—lung cancer	0.000327	0.00233	CcSEcCtD
Vecuronium—Dermatitis—Topotecan—lung cancer	0.000327	0.00233	CcSEcCtD
Vecuronium—Nervous system disorder—Cisplatin—lung cancer	0.000326	0.00232	CcSEcCtD
Vecuronium—Tachycardia—Cisplatin—lung cancer	0.000324	0.00231	CcSEcCtD
Vecuronium—Rash—Erlotinib—lung cancer	0.000323	0.0023	CcSEcCtD
Vecuronium—Dermatitis—Erlotinib—lung cancer	0.000323	0.0023	CcSEcCtD
Vecuronium—Angiopathy—Docetaxel—lung cancer	0.000323	0.0023	CcSEcCtD
Vecuronium—Skin disorder—Cisplatin—lung cancer	0.000323	0.0023	CcSEcCtD
Vecuronium—Immune system disorder—Docetaxel—lung cancer	0.000321	0.00229	CcSEcCtD
Vecuronium—Mediastinal disorder—Docetaxel—lung cancer	0.000321	0.00228	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000315	0.00225	CcSEcCtD
Vecuronium—Hypotension—Cisplatin—lung cancer	0.00031	0.00221	CcSEcCtD
Vecuronium—ABCB1—lung—lung cancer	0.00031	0.0081	CbGeAlD
Vecuronium—Face oedema—Doxorubicin—lung cancer	0.00031	0.00221	CcSEcCtD
Vecuronium—Erythema—Docetaxel—lung cancer	0.00031	0.00221	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000309	0.0022	CcSEcCtD
Vecuronium—Anaphylactic shock—Etoposide—lung cancer	0.000304	0.00217	CcSEcCtD
Vecuronium—Anaphylactic shock—Paclitaxel—lung cancer	0.000298	0.00213	CcSEcCtD
Vecuronium—Tachycardia—Etoposide—lung cancer	0.000297	0.00212	CcSEcCtD
Vecuronium—Skin disorder—Etoposide—lung cancer	0.000296	0.00211	CcSEcCtD
Vecuronium—Shock—Paclitaxel—lung cancer	0.000293	0.00209	CcSEcCtD
Vecuronium—Nervous system disorder—Paclitaxel—lung cancer	0.000293	0.00208	CcSEcCtD
Vecuronium—Tachycardia—Paclitaxel—lung cancer	0.000291	0.00207	CcSEcCtD
Vecuronium—Skin disorder—Paclitaxel—lung cancer	0.00029	0.00206	CcSEcCtD
Vecuronium—Hypotension—Etoposide—lung cancer	0.000284	0.00203	CcSEcCtD
Vecuronium—Muscular weakness—Doxorubicin—lung cancer	0.000283	0.00202	CcSEcCtD
Vecuronium—Rash—Vinorelbine—lung cancer	0.00028	0.00199	CcSEcCtD
Vecuronium—Dermatitis—Vinorelbine—lung cancer	0.000279	0.00199	CcSEcCtD
Vecuronium—Hypotension—Paclitaxel—lung cancer	0.000279	0.00199	CcSEcCtD
Vecuronium—Hypersensitivity—Irinotecan—lung cancer	0.000269	0.00192	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000262	0.00187	CcSEcCtD
Vecuronium—Anaphylactic shock—Docetaxel—lung cancer	0.000253	0.0018	CcSEcCtD
Vecuronium—Shock—Docetaxel—lung cancer	0.000249	0.00177	CcSEcCtD
Vecuronium—Nervous system disorder—Docetaxel—lung cancer	0.000248	0.00177	CcSEcCtD
Vecuronium—Tachycardia—Docetaxel—lung cancer	0.000247	0.00176	CcSEcCtD
Vecuronium—Skin disorder—Docetaxel—lung cancer	0.000246	0.00175	CcSEcCtD
Vecuronium—Hypersensitivity—Cisplatin—lung cancer	0.000245	0.00174	CcSEcCtD
Vecuronium—Urticaria—Etoposide—lung cancer	0.000242	0.00172	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—lung cancer	0.000238	0.0017	CcSEcCtD
Vecuronium—Urticaria—Paclitaxel—lung cancer	0.000237	0.00169	CcSEcCtD
Vecuronium—Hypotension—Docetaxel—lung cancer	0.000236	0.00168	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—lung cancer	0.000233	0.00166	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—lung cancer	0.000232	0.00165	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—lung cancer	0.000231	0.00165	CcSEcCtD
Vecuronium—Rash—Irinotecan—lung cancer	0.000231	0.00164	CcSEcCtD
Vecuronium—Dermatitis—Irinotecan—lung cancer	0.00023	0.00164	CcSEcCtD
Vecuronium—Rash—Gemcitabine—lung cancer	0.000225	0.0016	CcSEcCtD
Vecuronium—Dermatitis—Gemcitabine—lung cancer	0.000224	0.0016	CcSEcCtD
Vecuronium—Hypersensitivity—Etoposide—lung cancer	0.000224	0.0016	CcSEcCtD
Vecuronium—Erythema—Methotrexate—lung cancer	0.000223	0.00159	CcSEcCtD
Vecuronium—Hypersensitivity—Paclitaxel—lung cancer	0.00022	0.00157	CcSEcCtD
Vecuronium—Connective tissue disorder—Doxorubicin—lung cancer	0.000218	0.00155	CcSEcCtD
Vecuronium—ABCB1—lymph node—lung cancer	0.000212	0.00554	CbGeAlD
Vecuronium—Rash—Cisplatin—lung cancer	0.000209	0.00149	CcSEcCtD
Vecuronium—Dermatitis—Cisplatin—lung cancer	0.000209	0.00149	CcSEcCtD
Vecuronium—Cardiac disorder—Doxorubicin—lung cancer	0.000206	0.00147	CcSEcCtD
Vecuronium—Flushing—Doxorubicin—lung cancer	0.000206	0.00147	CcSEcCtD
Vecuronium—Angiopathy—Doxorubicin—lung cancer	0.000202	0.00144	CcSEcCtD
Vecuronium—Immune system disorder—Doxorubicin—lung cancer	0.000201	0.00143	CcSEcCtD
Vecuronium—Mediastinal disorder—Doxorubicin—lung cancer	0.0002	0.00143	CcSEcCtD
Vecuronium—Erythema—Doxorubicin—lung cancer	0.000193	0.00138	CcSEcCtD
Vecuronium—Rash—Etoposide—lung cancer	0.000192	0.00137	CcSEcCtD
Vecuronium—Dermatitis—Etoposide—lung cancer	0.000192	0.00137	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000189	0.00134	CcSEcCtD
Vecuronium—Rash—Paclitaxel—lung cancer	0.000188	0.00134	CcSEcCtD
Vecuronium—Dermatitis—Paclitaxel—lung cancer	0.000188	0.00134	CcSEcCtD
Vecuronium—Hypersensitivity—Docetaxel—lung cancer	0.000186	0.00133	CcSEcCtD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000185	0.000977	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—ALDOA—lung cancer	0.000184	0.000972	CbGpPWpGaD
Vecuronium—Anaphylactic shock—Methotrexate—lung cancer	0.000182	0.0013	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—lung cancer	0.000179	0.00127	CcSEcCtD
Vecuronium—SLC22A1—Neuronal System—GRIK3—lung cancer	0.000178	0.000941	CbGpPWpGaD
Vecuronium—Skin disorder—Methotrexate—lung cancer	0.000177	0.00126	CcSEcCtD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000176	0.00093	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—ABCG2—lung cancer	0.000174	0.000918	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—AKT1—lung cancer	0.00017	0.000901	CbGpPWpGaD
Vecuronium—Hypotension—Methotrexate—lung cancer	0.00017	0.00121	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000163	0.00116	CcSEcCtD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—TF—lung cancer	0.000161	0.000853	CbGpPWpGaD
Vecuronium—Rash—Docetaxel—lung cancer	0.000159	0.00114	CcSEcCtD
Vecuronium—Dermatitis—Docetaxel—lung cancer	0.000159	0.00113	CcSEcCtD
Vecuronium—Anaphylactic shock—Doxorubicin—lung cancer	0.000158	0.00112	CcSEcCtD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000157	0.000831	CbGpPWpGaD
Vecuronium—Shock—Doxorubicin—lung cancer	0.000155	0.00111	CcSEcCtD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000155	0.000819	CbGpPWpGaD
Vecuronium—Nervous system disorder—Doxorubicin—lung cancer	0.000155	0.0011	CcSEcCtD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—ENO1—lung cancer	0.000155	0.000818	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000154	0.000816	CbGpPWpGaD
Vecuronium—Tachycardia—Doxorubicin—lung cancer	0.000154	0.0011	CcSEcCtD
Vecuronium—Skin disorder—Doxorubicin—lung cancer	0.000153	0.00109	CcSEcCtD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—lung cancer	0.000151	0.000801	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000149	0.00079	CbGpPWpGaD
Vecuronium—Hypotension—Doxorubicin—lung cancer	0.000147	0.00105	CcSEcCtD
Vecuronium—SLC22A1—Neuronal System—CHRNB4—lung cancer	0.000145	0.000767	CbGpPWpGaD
Vecuronium—Urticaria—Methotrexate—lung cancer	0.000145	0.00103	CcSEcCtD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000143	0.000758	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—BRAF—lung cancer	0.000139	0.000735	CbGpPWpGaD
Vecuronium—ABCB1—ABC-family proteins mediated transport—APOA1—lung cancer	0.000139	0.000734	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000136	0.000718	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—GNG11—lung cancer	0.000136	0.000717	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—CHRNA5—lung cancer	0.000135	0.000713	CbGpPWpGaD
Vecuronium—Hypersensitivity—Methotrexate—lung cancer	0.000134	0.000956	CcSEcCtD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000132	0.000696	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000131	0.000694	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	0.000129	0.000683	CbGpPWpGaD
Vecuronium—Urticaria—Doxorubicin—lung cancer	0.000125	0.000893	CcSEcCtD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000125	0.000662	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000125	0.000659	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000122	0.000645	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—BRAF—lung cancer	0.000118	0.000625	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—MDM2—lung cancer	0.000116	0.000616	CbGpPWpGaD
Vecuronium—Hypersensitivity—Doxorubicin—lung cancer	0.000116	0.000828	CcSEcCtD
Vecuronium—CHRND—Transmission across Chemical Synapses—RAF1—lung cancer	0.000116	0.000614	CbGpPWpGaD
Vecuronium—Rash—Methotrexate—lung cancer	0.000115	0.000819	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—lung cancer	0.000115	0.000818	CcSEcCtD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	0.000113	0.000597	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000112	0.000594	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—CHRNA3—lung cancer	0.00011	0.000581	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	0.000107	0.000566	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	0.000107	0.000566	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—BRAF—lung cancer	0.000106	0.000563	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—GNG11—lung cancer	0.000104	0.000549	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000103	0.000544	CbGpPWpGaD
Vecuronium—Rash—Doxorubicin—lung cancer	9.95e-05	0.000709	CcSEcCtD
Vecuronium—Dermatitis—Doxorubicin—lung cancer	9.94e-05	0.000708	CcSEcCtD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	9.91e-05	0.000524	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—MDM2—lung cancer	9.9e-05	0.000524	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—RAF1—lung cancer	9.87e-05	0.000522	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—MDM2—lung cancer	9.41e-05	0.000497	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—RAF1—lung cancer	9.37e-05	0.000496	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—ADCY1—lung cancer	9.34e-05	0.000494	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—TERT—lung cancer	9.26e-05	0.00049	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL10—lung cancer	9.1e-05	0.000481	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—BRAF—lung cancer	9.05e-05	0.000479	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—MDM2—lung cancer	8.92e-05	0.000472	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—RAF1—lung cancer	8.89e-05	0.00047	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—HIF1A—lung cancer	8.86e-05	0.000469	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—BRAF—lung cancer	8.6e-05	0.000455	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	8.5e-05	0.000449	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—FASLG—lung cancer	8.46e-05	0.000448	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	8.32e-05	0.00044	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	7.96e-05	0.000421	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—MDM2—lung cancer	7.59e-05	0.000401	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—RAF1—lung cancer	7.56e-05	0.0004	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	7.27e-05	0.000385	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	7.24e-05	0.000383	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	7.23e-05	0.000382	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—MDM2—lung cancer	7.21e-05	0.000381	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—RAF1—lung cancer	7.18e-05	0.00038	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—COL4A3BP—lung cancer	6.95e-05	0.000368	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AZIN2—lung cancer	6.95e-05	0.000368	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	6.87e-05	0.000363	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	6.48e-05	0.000343	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—HRAS—lung cancer	6.39e-05	0.000338	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—AVP—lung cancer	6.37e-05	0.000337	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP8—lung cancer	6.3e-05	0.000333	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCC3—lung cancer	6.16e-05	0.000326	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	6.14e-05	0.000325	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	6.03e-05	0.000319	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ATP5H—lung cancer	5.91e-05	0.000313	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	5.82e-05	0.000308	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—GNG11—lung cancer	5.59e-05	0.000295	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	5.45e-05	0.000288	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—HRAS—lung cancer	5.43e-05	0.000287	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	5.34e-05	0.000283	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	5.28e-05	0.000279	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PLBD1—lung cancer	5.27e-05	0.000279	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—HRAS—lung cancer	5.16e-05	0.000273	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—BRAF—lung cancer	5.16e-05	0.000273	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ADCY1—lung cancer	5.02e-05	0.000266	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCG2—lung cancer	5.02e-05	0.000266	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CXCL8—lung cancer	4.98e-05	0.000263	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	4.93e-05	0.000261	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—HRAS—lung cancer	4.9e-05	0.000259	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSD17B10—lung cancer	4.82e-05	0.000255	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP3—lung cancer	4.76e-05	0.000252	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL2—lung cancer	4.76e-05	0.000252	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—TF—lung cancer	4.67e-05	0.000247	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	4.67e-05	0.000247	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	4.55e-05	0.00024	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CKB—lung cancer	4.48e-05	0.000237	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—MDM2—lung cancer	4.32e-05	0.000228	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—RAF1—lung cancer	4.31e-05	0.000228	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CNDP2—lung cancer	4.21e-05	0.000223	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTM2—lung cancer	4.21e-05	0.000223	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	4.18e-05	0.000221	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—HRAS—lung cancer	4.16e-05	0.00022	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTMR3—lung cancer	4.1e-05	0.000217	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—COL4A3BP—lung cancer	4.07e-05	0.000215	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AZIN2—lung cancer	4.07e-05	0.000215	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—VEGFA—lung cancer	4.04e-05	0.000214	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PGAM1—lung cancer	3.99e-05	0.000211	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—HRAS—lung cancer	3.95e-05	0.000209	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—BRAF—lung cancer	3.95e-05	0.000209	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—lung cancer	3.86e-05	0.000204	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.84e-05	0.000203	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2A7—lung cancer	3.81e-05	0.000201	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SDC4—lung cancer	3.73e-05	0.000197	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	3.61e-05	0.000191	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ATP5H—lung cancer	3.46e-05	0.000183	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—RRM1—lung cancer	3.39e-05	0.000179	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA3—lung cancer	3.39e-05	0.000179	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.34e-05	0.000176	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—MDM2—lung cancer	3.31e-05	0.000175	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—RAF1—lung cancer	3.3e-05	0.000174	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.3e-05	0.000174	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	3.27e-05	0.000173	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—AVP—lung cancer	3.24e-05	0.000171	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—B4GALT5—lung cancer	3.19e-05	0.000169	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—lung cancer	3.14e-05	0.000166	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	3.11e-05	0.000164	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA4—lung cancer	3.1e-05	0.000164	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	3.09e-05	0.000164	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PLBD1—lung cancer	3.09e-05	0.000163	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA2—lung cancer	3.03e-05	0.00016	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.98e-05	0.000158	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.95e-05	0.000156	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	2.94e-05	0.000156	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	2.94e-05	0.000156	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA1—lung cancer	2.92e-05	0.000154	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCC3—lung cancer	2.89e-05	0.000153	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSD17B10—lung cancer	2.82e-05	0.000149	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AKR1C1—lung cancer	2.8e-05	0.000148	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.74e-05	0.000145	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—UGT1A1—lung cancer	2.71e-05	0.000143	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.63e-05	0.000139	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CKB—lung cancer	2.63e-05	0.000139	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.62e-05	0.000138	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GNG11—lung cancer	2.62e-05	0.000138	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.59e-05	0.000137	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.53e-05	0.000134	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALDOA—lung cancer	2.49e-05	0.000132	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—APOA1—lung cancer	2.48e-05	0.000131	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTM2—lung cancer	2.47e-05	0.000131	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CNDP2—lung cancer	2.47e-05	0.000131	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA3—lung cancer	2.42e-05	0.000128	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTMR3—lung cancer	2.4e-05	0.000127	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—HRAS—lung cancer	2.37e-05	0.000125	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ADCY1—lung cancer	2.35e-05	0.000124	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCG2—lung cancer	2.35e-05	0.000124	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.35e-05	0.000124	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PGAM1—lung cancer	2.34e-05	0.000124	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ENO2—lung cancer	2.31e-05	0.000122	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HPGDS—lung cancer	2.31e-05	0.000122	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPP2R1B—lung cancer	2.29e-05	0.000121	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.29e-05	0.000121	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.28e-05	0.000121	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTT1—lung cancer	2.24e-05	0.000118	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2A7—lung cancer	2.23e-05	0.000118	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.21e-05	0.000117	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GCLC—lung cancer	2.21e-05	0.000117	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2A6—lung cancer	2.21e-05	0.000117	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.21e-05	0.000117	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SDC4—lung cancer	2.18e-05	0.000116	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.11e-05	0.000111	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ENO1—lung cancer	2.1e-05	0.000111	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.1e-05	0.000111	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.05e-05	0.000108	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2e-05	0.000106	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—RRM1—lung cancer	1.99e-05	0.000105	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA3—lung cancer	1.99e-05	0.000105	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ALB—lung cancer	1.96e-05	0.000104	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.9e-05	0.0001	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.89e-05	9.98e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2E1—lung cancer	1.88e-05	9.95e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—B4GALT5—lung cancer	1.87e-05	9.89e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NQO1—lung cancer	1.86e-05	9.83e-05	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.84e-05	9.71e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA4—lung cancer	1.82e-05	9.62e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—HRAS—lung cancer	1.82e-05	9.61e-05	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.8e-05	9.49e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	1.77e-05	9.38e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA2—lung cancer	1.77e-05	9.38e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA1—lung cancer	1.71e-05	9.05e-05	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.7e-05	8.97e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ABCC3—lung cancer	1.69e-05	8.95e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—STK11—lung cancer	1.68e-05	8.87e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AKR1C1—lung cancer	1.64e-05	8.66e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UGT1A1—lung cancer	1.59e-05	8.41e-05	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.56e-05	8.24e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTP1—lung cancer	1.55e-05	8.2e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GNG11—lung cancer	1.53e-05	8.11e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CAT—lung cancer	1.51e-05	7.98e-05	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.51e-05	7.97e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCB1—lung cancer	1.47e-05	7.76e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALDOA—lung cancer	1.46e-05	7.72e-05	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.45e-05	7.67e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TYMS—lung cancer	1.44e-05	7.63e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTM1—lung cancer	1.43e-05	7.54e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA3—lung cancer	1.42e-05	7.5e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ABCG2—lung cancer	1.38e-05	7.29e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ADCY1—lung cancer	1.38e-05	7.29e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ENO2—lung cancer	1.35e-05	7.15e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HPGDS—lung cancer	1.35e-05	7.15e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP1A1—lung cancer	1.35e-05	7.15e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPP2R1B—lung cancer	1.34e-05	7.11e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ERCC2—lung cancer	1.34e-05	7.09e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTT1—lung cancer	1.31e-05	6.94e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GCLC—lung cancer	1.3e-05	6.86e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2A6—lung cancer	1.3e-05	6.86e-05	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.27e-05	6.73e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ENO1—lung cancer	1.23e-05	6.5e-05	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.23e-05	6.49e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—APOA1—lung cancer	1.16e-05	6.13e-05	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.15e-05	6.08e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2E1—lung cancer	1.1e-05	5.83e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NQO1—lung cancer	1.09e-05	5.76e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CG—lung cancer	1.06e-05	5.6e-05	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.04e-05	5.5e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—POMC—lung cancer	1.01e-05	5.33e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—STK11—lung cancer	9.83e-06	5.2e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CREBBP—lung cancer	9.81e-06	5.19e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CD—lung cancer	9.31e-06	4.92e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALB—lung cancer	9.19e-06	4.86e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTP1—lung cancer	9.09e-06	4.81e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CAT—lung cancer	8.85e-06	4.68e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TYMS—lung cancer	8.45e-06	4.47e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTM1—lung cancer	8.36e-06	4.42e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CB—lung cancer	8.11e-06	4.29e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTGS2—lung cancer	8.04e-06	4.25e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP1A1—lung cancer	7.92e-06	4.19e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ERCC2—lung cancer	7.86e-06	4.15e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTEN—lung cancer	7.01e-06	3.71e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—APOA1—lung cancer	6.8e-06	3.59e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—EP300—lung cancer	6.68e-06	3.53e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CG—lung cancer	6.2e-06	3.28e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—POMC—lung cancer	5.91e-06	3.12e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CREBBP—lung cancer	5.75e-06	3.04e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CD—lung cancer	5.45e-06	2.88e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALB—lung cancer	5.38e-06	2.85e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CA—lung cancer	4.94e-06	2.61e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CB—lung cancer	4.75e-06	2.51e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTGS2—lung cancer	4.71e-06	2.49e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTEN—lung cancer	4.11e-06	2.17e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AKT1—lung cancer	4.04e-06	2.14e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—EP300—lung cancer	3.92e-06	2.07e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CA—lung cancer	2.9e-06	1.53e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AKT1—lung cancer	2.37e-06	1.25e-05	CbGpPWpGaD
